Radioligand Therapy (RLT) is advancing rapidly, with new developments improving targeting precision and expanding treatment opportunities for patients with difficult-to-treat cancers. Translational research is accelerating the path from innovation to clinical practice, strengthening the role of nuclear medicine within modern oncology.
This webinar will provide an overview of what cancer centres can offer today, highlight expected advances in the coming years, and discuss the most promising emerging agents in the RLT landscape.